These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 6451987

  • 21. Adolescent satisfaction with postpartum contraception and body weight concerns.
    Hellerstedt WL, Story M.
    J Adolesc Health; 1998 Jun; 22(6):446-52. PubMed ID: 9627814
    [Abstract] [Full Text] [Related]

  • 22. Forearm bone density in users of Depo-Provera as a contraceptive method.
    Bahamondes L, Perrotti M, Castro S, Faúndes D, Petta C, Bedone A.
    Fertil Steril; 1999 May; 71(5):849-52. PubMed ID: 10231044
    [Abstract] [Full Text] [Related]

  • 23. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives.
    Moore LL, Valuck R, McDougall C, Fink W.
    Contraception; 1995 Oct; 52(4):215-9. PubMed ID: 8605778
    [Abstract] [Full Text] [Related]

  • 24. Prevalence of visible disruption of cervical epithelium and cervical ectopy in African women using Depo-Provera.
    Kuhn L, Denny L, Pollack AE, Wright TC.
    Contraception; 1999 Jun; 59(6):363-7. PubMed ID: 10518230
    [Abstract] [Full Text] [Related]

  • 25. The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy.
    Mauck CK, Callahan MM, Baker J, Arbogast K, Veazey R, Stock R, Pan Z, Morrison CS, Chen-Mok M, Archer DF, Gabelnick HL.
    Contraception; 1999 Jul; 60(1):15-24. PubMed ID: 10549448
    [Abstract] [Full Text] [Related]

  • 26. Some effects of depo-medroxyprogesterone acetate (DMPA): observations in the nursing infant and in the long-term user.
    Dahlberg K.
    Int J Gynaecol Obstet; 1982 Feb; 20(1):43-8. PubMed ID: 6126406
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. In utero exposure to steroid contraceptives and outcome of pregnancy.
    Pardthaisong T, Gray RH.
    Am J Epidemiol; 1991 Oct 15; 134(8):795-803. PubMed ID: 1835282
    [Abstract] [Full Text] [Related]

  • 29. Depo-provera: contraceptive risk?
    Rosenfield A.
    Hastings Cent Rep; 1980 Apr 15; 10(2):4. PubMed ID: 6445344
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Depo-Provera highly effective as injectable contraceptive.
    Denniston GC.
    Contracept Technol Update; 1985 Dec 15; 6(12):167-8. PubMed ID: 12280301
    [Abstract] [Full Text] [Related]

  • 33. Reply to Dr. Edwin B. McDaniel. Exaggerated claims of depo-provera safety.
    Minkin SF.
    Women Health; 1981 Dec 15; 6(1-2):125-9. PubMed ID: 6223451
    [Abstract] [Full Text] [Related]

  • 34. Extracts from the report on the Joint IGCC/IFRP East and South East Asia Seminar on Regional Fertility Research.
    Mcdaniel EB.
    IGCC News; 1980 Jan 15; 5(3):1-4. PubMed ID: 12179403
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetic study of different doses of Depo Provera.
    Fotherby K, Koetsawang S, Mathrubutham M.
    Contraception; 1980 Nov 15; 22(5):527-36. PubMed ID: 6451351
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The use of Depo-Provera in East London.
    Savage W.
    Fertil Contracept; 1978 Jul 15; 2(3):41-7. PubMed ID: 12260723
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Medroxyprogesterone acetate [Depo Provera] injections. Development of striae.
    Gupta M.
    Br J Fam Plann; 2000 Apr 15; 26(2):104-5. PubMed ID: 10773604
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.